Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Cost of Revenue (2016 - 2025)

Fortress Biotech has reported Cost of Revenue over the past 10 years, most recently at $5.4 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $5.4 million for Q4 2025, up 16.24% from a year ago — trailing twelve months through Dec 2025 was $20.9 million (changed 0.21% YoY), and the annual figure for FY2025 was $20.9 million, changed 0.22%.
  • Cost of Revenue for Q4 2025 was $5.4 million at Fortress Biotech, down from $5.8 million in the prior quarter.
  • Over the last five years, Cost of Revenue for FBIO hit a ceiling of $11.2 million in Q3 2021 and a floor of $2.2 million in Q4 2023.
  • Median Cost of Revenue over the past 5 years was $6.2 million (2023), compared with a mean of $6.4 million.
  • Biggest five-year swings in Cost of Revenue: soared 230.48% in 2021 and later tumbled 70.87% in 2023.
  • Fortress Biotech's Cost of Revenue stood at $9.5 million in 2021, then decreased by 18.97% to $7.7 million in 2022, then tumbled by 70.87% to $2.2 million in 2023, then surged by 108.19% to $4.7 million in 2024, then increased by 16.24% to $5.4 million in 2025.
  • The last three reported values for Cost of Revenue were $5.4 million (Q4 2025), $5.8 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.